PI3K/AKT/mTOR通路
蛋白激酶B
P70-S6激酶1
RPTOR公司
核糖体s6激酶
激酶
癌症研究
核糖体蛋白s6
细胞周期蛋白依赖激酶2
生物
mTORC1型
化学
细胞生长
磷酸化
细胞生物学
蛋白激酶A
信号转导
分子生物学
生物化学
作者
Sanmei Chen,Takeshi Nakahara,Hiroshi Uchi,Satoshi Takeuchi,Masahiro Takahara,M. Kido,Long Dugu,Yuexing Tu,Y. Moroi,Masutaka Furue
标识
DOI:10.1111/j.1365-2133.2009.09179.x
摘要
The activation of the AKT-mTOR-p70S6K pathway may play an important role in the pathogenesis of EMPD. The high expression of the components of the pathway was highly correlated with CDK2 expression, suggesting that the AKT/mTOR pathway may induce the malignant transition through CDK2 in EMPD. The AKT-mTOR-p70S6K pathway might be a potential therapeutic target in EMPD.
科研通智能强力驱动
Strongly Powered by AbleSci AI